Internal Medicine · Flint, MI
NPI
1992841423
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5061 Villa Linde Pkwy
Flint, MI, 48532
Phone (810) 733-6000
Medicare paid, 2024
$114K
2,334 services
Medicare patients, 2024
368
Average age 76
Drug cost, 2024
$2.6M
19,640 prescriptions
Company payments, 2025
$252
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Miguel F Perez-Pascual was code 99213 (office e&m - established), 873 times for 304 patients. In total Miguel F Perez-Pascual billed 2,334 services in 54 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 873 | 304 | $53.61 | $47K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 267 | 37 | $0.62 | $167 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 192 | 192 | $123.73 | $24K |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 143 | 143 | $17.69 | $2,530 |
| 99214 Office E&M - Established | Office | 123 | 80 | $88.17 | $11K |
| 93000 Electrocardiogram | Office | 116 | 112 | $7.87 | $913 |
| G0102 Prostate cancer screening; digital rectal examination | Office | 97 | 97 | $12.33 | $1,196 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 82 | 82 | $17.66 | $1,448 |
| 96372 Injection Administration | Office | 74 | 21 | $9.55 | $707 |
| 90662 Vaccine Product | Office | 54 | 54 | $73.50 | $3,969 |
| G0008 Administration of influenza virus vaccine | Office | 54 | 54 | $30.87 | $1,667 |
| 17000 Destruction Skin Lesion | Office | 32 | 23 | $43.82 | $1,402 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 22 | 21 | $140.29 | $3,086 |
| 20610 Joint Injection | Office | 21 | 14 | $43.10 | $905 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 21 | 20 | $194.29 | $4,080 |
By year: 2022 $108K for 2,233 services; 2023 $112K for 2,209 services; 2024 $114K for 2,334 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 143 | 143 | $17.69 | $2,530 |
| 82274 Immunoassay | 12 | 12 | $15.60 | $187 |
Medicare prescription drug claims, 2024
In 2024, the drug Miguel F Perez-Pascual prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,030 prescriptions and refills. In total Miguel F Perez-Pascual wrote 19,640 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,030 | 2,666 | 301 | $14K |
| Levothyroxine Sodium Generic | 975 | 2,614 | 253 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 807 | 807 | 172 | $9,586 |
| Methylprednisolone Generic | 667 | 681 | 374 | $4,529 |
| Alprazolam Generic | 545 | 631 | 120 | $2,839 |
| Lisinopril Generic | 520 | 1,466 | 156 | $4,963 |
| Amlodipine Besylate Generic | 440 | 1,179 | 126 | $3,714 |
| Simvastatin Generic | 379 | 955 | 103 | $3,580 |
| Metoprolol Succinate Generic | 334 | 913 | 108 | $5,656 |
| Omeprazole Generic | 330 | 863 | 119 | $4,290 |
| Glipizide Er Glipizide | 294 | 698 | 75 | $5,684 |
| Metoprolol Tartrate Generic | 289 | 775 | 115 | $2,230 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 288 | 749 | 93 | $3,362 |
| Tramadol Hcl Generic | 285 | 289 | 72 | $970 |
| Rosuvastatin Calcium Generic | 283 | 739 | 119 | $5,570 |
Brand drugs: 2,731 claims; generic drugs: 16,766 claims; opioid claims: 1,283.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Miguel F Perez-Pascual $252 ($252 in general payments such as food, travel and fees) from 9 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $84.22.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $84.22 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $29.44 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $24.2 |
| Novo Nordisk Inc NVO | 1 | $22.17 |
| Lilly USA, LLC LLY | 1 | $20.39 |
| Corcept Therapeutics CORT | 1 | $19.49 |
| Abbott Laboratories ABT | 1 | $18.2 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $18.07 |
| GlaxoSmithKline, LLC. GSK | 1 | $15.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.